Inflammatory Breast Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast CancerInterventions: Drug: MK-3475; Behavioral: Follow Up/Phone CallSponsors: M.D. Anderson Cancer Center; Merck Sharp & Dohme Corp.Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2015 Category: Research Source Type: clinical trials
MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast CancerInterventions: Drug: MK-3475; Behavioral: Follow Up/Phone CallSponsors: M.D. Anderson Cancer Center; Merck Sharp & Dohme Corp.Not yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2015 Category: Research Source Type: clinical trials
MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast CancerInterventions: Drug: MK-3475; Behavioral: Follow Up/Phone CallSponsors: M.D. Anderson Cancer Center; Merck Sharp & Dohme Corp.Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2015 Category: Research Source Type: clinical trials
Nintedanib For HER2-negative Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast CancerInterventions: Drug: BIBF 1120; Behavioral: Phone CallSponsors: M.D. Anderson Cancer Center; Boehringer IngelheimNot yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2015 Category: Research Source Type: clinical trials
Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer
Condition: Inflammatory Breast CancerInterventions: Drug: Docetaxel; Drug: Cyclophosphamide; Drug: EpirubicinSponsor: UNICANCERCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2014 Category: Research Source Type: clinical trials
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Conditions: HER2-negative Breast Cancer; Inflammatory Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast CancerInterventions: Drug: Romidepsin; Drug: AbraxaneSponsors: Thomas Jefferson University; Celgene CorporationRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2013 Category: Research Source Type: clinical trials